Skip to main content

Leonard Braden Michael's Form 4/A amendment

Amended

Adverum Biotechnologies, Inc. (ADVM) · filed Apr 28, 2025

Accession no.
0001373604-25-000069
Filed
Apr 28, 2025
Trade date
Mar 26-27, 2025
Filing delay
33 days
Rule 10b5-1 plan
Not checked
Original filed
Mar 27, 2025

This filing lists 2 non-derivative transactions. Open-market purchases total $189.0K. It was filed 33 days after the trade.

This amendment replaces 0001373604-25-000056 (filed Mar 27, 2025).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Leonard Braden MichaelCIK 000137360310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 26, 2025Common StockPPurchaseAcquired+20,407$5.04F1+$102,851.28125,207DirectDuplicate filing
Mar 27, 2025Common StockPPurchaseAcquired+16,593$5.19F2+$86,117.67141,800DirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $5.0395 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares bought at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F2

Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $5.1883 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares bought at each separate price within the range

Referenced by the price of 1 transaction in Table I.

F3

BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

F4

This amendment is being filed to correct BOX 4 on the transaction date of 3/27/25 to correct a clerical error. BOX 4 has been amended to "A", as the shares were acquired, not disposed.

Remarks

This amendment is being filed to indicate Form 4/A instead of previous amendment indicating Form 4.

Read the full filing on SEC EDGAR (opens in a new tab)